Cabaletta Bio, Inc. (CABA): Valuation
TTM figures as of June 30, 2026
Cabaletta Bio, Inc. trades at a -33.32% free-cash-flow yield. That FCF yield is higher than 42% of its own month-end history back to 2019.
Earnings yield -39.17%. ROIC -2,680.3%. Net cash $205.1M.
83 month-end valuation observations are on file, starting October 2019.
Sector comparison uses 2682 Healthcare names.
Frequently asked questions
Is CABA cheap versus its own history?
Cabaletta Bio, Inc. trades at a -33.32% free-cash-flow yield. That FCF yield is higher than 42% of its own month-end history back to 2019.
What is CABA's free-cash-flow yield?
Cabaletta Bio, Inc. currently yields -33.32% of market cap as trailing free cash flow.
Where do these valuation figures come from?
Yields and quality metrics are computed from the same SEC TTM figures as the financials page, against the live market cap. Historical bands reconstruct month-end market cap from split-adjusted closes and the share count in the units it was filed, then divide by those dollar totals. Nothing here is a third-party estimate.